Asia-Pacific Injection Pen Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Asia-Pacific Injection Pen Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Asia-Pacific Injection Pen Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Higher Prevalence of Chronic Disorders Boosting Market Growth

5.2 Market Opportunities

5.2.1 Increasing Biologics Patent Expiry and Use of Biosimilars Generating the Demand for Injection Pens

5.3 Future Trends

5.3.1 Strategic Developments by Various Players Favouring Market Growth

5.4 Impact of Drivers and Restraints

6. Asia-Pacific Injection Pen Market Regional Analysis

6.1 Asia-Pacific Injection Pen Market Overview

6.2 Asia-Pacific Injection Pen Market Revenue 2020-2028 (US$ Million)

6.3 Asia-Pacific Injection Pen Market Forecast Analysis

7. Asia-Pacific Injection Pen Market Analysis – by Type

7.1 Disposable Injection Pens

7.1.1 Overview
7.1.2 Disposable Injection Pens: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Reusable Injection Pens

7.2.1 Overview
7.2.2 Reusable Injection Pens: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia-Pacific Injection Pen Market Analysis – by Therapy

8.1 Diabetes

8.1.1 Overview
8.1.2 Diabetes: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Growth Hormone Therapy

8.2.1 Overview
8.2.2 Growth Hormone Therapy: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Autoimmune Diseases

8.3.1 Overview
8.3.2 Autoimmune Diseases: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Fertility

8.4.1 Overview
8.4.2 Fertility: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Cancer

8.5.1 Overview
8.5.2 Cancer: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others Therapy

8.6.1 Overview
8.6.2 Others Therapy: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia-Pacific Injection Pen Market Analysis – by End User

9.1 Hospitals and Clinics

9.1.1 Overview
9.1.2 Others Therapy: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Home Care

9.2.1 Overview
9.2.2 Others Therapy: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

10. Asia-Pacific Injection Pen Market – Asia-Pacific Analysis

10.1 Asia-Pacific

10.1.1 Asia-Pacific Injection Pen Market Breakdown, by Key Country, 2023 and 2028 (%)
10.1.1.1 Asia-Pacific Injection Pen Market – Revenue and Forecast Analysis – by Country
10.1.1.1 China: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 China: Asia-Pacific Injection Pen Market Breakdown, by Type
10.1.1.1.2 China: Asia-Pacific Injection Pen Market Breakdown, by Therapy
10.1.1.1.3 China: Asia-Pacific Injection Pen Market Breakdown, by End User

10.1.1.2 India: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 India: Asia-Pacific Injection Pen Market Breakdown, by Type
10.1.1.2.2 India: Asia-Pacific Injection Pen Market Breakdown, by Therapy
10.1.1.2.3 India: Asia-Pacific Injection Pen Market Breakdown, by End User

10.1.1.3 Japan: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Japan: Asia-Pacific Injection Pen Market Breakdown, by Type
10.1.1.3.2 Japan: Asia-Pacific Injection Pen Market Breakdown, by Therapy
10.1.1.3.3 Japan: Asia-Pacific Injection Pen Market Breakdown, by End User

10.1.1.4 Australia: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Australia: Asia-Pacific Injection Pen Market Breakdown, by Type
10.1.1.4.2 Australia: Asia-Pacific Injection Pen Market Breakdown, by Therapy
10.1.1.4.3 Australia: Asia-Pacific Injection Pen Market Breakdown, by End User

10.1.1.5 Rest of Asia-Pacific : Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Rest of Asia-Pacific : Asia-Pacific Injection Pen Market Breakdown, by Type
10.1.1.5.2 Rest of Asia-Pacific : Asia-Pacific Injection Pen Market Breakdown, by Therapy
10.1.1.5.3 Rest of Asia-Pacific : Asia-Pacific Injection Pen Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Asia-Pacific Injection Pen Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 AstraZeneca Plc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Becton Dickinson and Co

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Eli Lilly and Co

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Gerresheimer AG

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Haselmeier GmbH

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Merck KGaA

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Novo Nordisk AS

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Owen Mumford Ltd

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Sanofi SA

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Teva Pharmaceutical Industries Ltd

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights